Indications and uses
For treatment of acne. Penetrates pores to eliminate most acne blemishes.
For treatment of acne. Penetrates pores to eliminate most acne blemishes.
Cleanse the skin thoroughly before applying this product. Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a physician. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Drug Facts
Salicylic Acid (2.0%)
Acne Treatment
Water (Aqua), Glycerin, Potassium Azeloyl Diglycinate, Propanediol, Dimethicone, Polyacrylate Crosspolymer-6, Silver, Morinda Citrifolia Extract, Narcissus Tazetta Bulb Extract, Schizandra Chinensis Fruit Extract, Dimethicone Crosspolymer, Hydrogenated Lecithin, Polyphosphorylcholine Glycol Acrylate, Butylene Glycol, Sodium Polyacrylate, Potassium Chloride, Ethylhexylglycerin, Phenoxyethanol, Sodium Benzoate, Citric Acid, Sodium Hydroxide.
1-800-487-1000
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62839-2539-1 | ageLOC LumiSpa Blemish Serum | 30 mL in 1 BOTTLE | LOTION | 30 | 1 | |
| 62839-2539-1 | ageLOC LumiSpa Blemish Serum | 1 in 1 CARTON | LOTION | 1 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62839-2539 | 62839-2539-1 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ageLOC LumiSpa Blemish Serum | SALICYLIC ACID | NSE Products, Inc. | 35cdc16c-9a51-4ee9-b39d-36f29c4176ae | 2026-04-01 | Warnings | 62839-2539-1 62839-2539 62839253901 9e381957-f5f8-4fd9-84ce-78652328afeb 35cdc16c-9a51-4ee9-b39d-36f29c4176ae |
Adverse event summaries are temporarily unavailable. Other product information remains available.